High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells
Authors
Keywords
Myocardial infarction, Heart, Histology, Bone marrow transplantation, Endothelial cells, Stem cell therapy, Mesenchymal stem cells, Neurobiology of disease and regeneration
Journal
PLoS One
Volume 15, Issue 4, Pages e0230392
Publisher
Public Library of Science (PLoS)
Online
2020-04-11
DOI
10.1371/journal.pone.0230392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
- (2018) Hirotatsu Ohkawara et al. BMC BIOTECHNOLOGY
- Intravital imaging with two-photon microscopy reveals cellular dynamics in the ischeamia-reperfused rat heart
- (2018) Ryohei Matsuura et al. Scientific Reports
- Novel trends in application of stem cells in skin wound healing
- (2018) Marek Kucharzewski et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster
- (2018) Takashi Kido et al. PLoS One
- Long-term effectiveness of local BM-MSCs for skeletal muscle regeneration: a proof of concept obtained on a pig model of severe radiation burn
- (2018) Christine Linard et al. Stem Cell Research & Therapy
- The angiogenic properties of human adipose-derived stem cells (HASCs) are modulated by the High mobility group box protein 1 (HMGB1)
- (2017) Federico Biscetti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
- (2015) Satsuki Fukushima et al. HEART FAILURE REVIEWS
- Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
- (2015) Samuel Golpanian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα+ mesenchymal cells from bone marrow
- (2015) Eriko Aikawa et al. Scientific Reports
- Intra-Arterial Transplantation of Low-Dose Stem Cells Provides Functional Recovery Without Adverse Effects After Stroke
- (2014) Yuhtaka Fukuda et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Application of stem cell/growth factor system, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields
- (2014) Fatemeh Pourrajab et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
- (2014) Seiichiro Higo et al. PLoS One
- Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model
- (2012) M. Kawamura et al. CIRCULATION
- Myoblast Sheet Can Prevent the Impairment of Cardiac Diastolic Function and Late Remodeling After Left Ventricular Restoration in Ischemic Cardiomyopathy
- (2012) Shunsuke Saito et al. TRANSPLANTATION
- High-mobility group box family of proteins: ligand and sensor for innate immunity
- (2012) Hideyuki Yanai et al. TRENDS IN IMMUNOLOGY
- Concise Review: Role of Mesenchymal Stem Cells in Wound Repair
- (2012) Scott Maxson et al. Stem Cells Translational Medicine
- PDGFR -positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia
- (2011) K. Tamai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue-Engineered Cardiac Constructs for Cardiac Repair
- (2010) Shigeru Miyagawa et al. ANNALS OF THORACIC SURGERY
- High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism
- (2010) F. Biscetti et al. DIABETES
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
- (2008) Mihaela Crisan et al. Cell Stem Cell
- Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart
- (2008) K. Takahashi et al. CIRCULATION
- HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells
- (2008) Alessandra Rossini et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More